AusperBio
PrivateLast Round
Series C
Aug 27, 2026
Total Funding Raised
$356.7M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
AusperBio is a biopharmaceutical company that develops targeted oligonucleotide therapeutics for the treatment of chronic hepatitis B and other liver diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AusperBio Comparables
Compare AusperBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mirum Pharmaceuticals | 83% | |
| Arbutus Biopharma Corp | 79% | |
| Aligos Therapeutics | 78% | |
AusperBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 27, 2026 | ||||
| Series B Extension | Sep 21, 2025 | ||||
| Series B Extension | May 28, 2025 | ||||
| Series B | Dec 26, 2024 | ||||
| Series A | Jul 14, 2024 | ||||
Seed | Nov 7, 2023 |
AusperBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CDH Investments | Series B Extension, Series B |
| RA Capital Management | Series C |
| Genesis Capital | Series B Extension |
| YuanBio Venture Capital | Series B Extension, Series B, Series A, Series C |
| Genesis Capital | Series B Extension, Series A |
| Sherpa Capital | Series B Extension, Series B |
| Sherpa Capital | Series B Extension, Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2026
$120M round with participation from CDH Investments and Hankang Capital.
- Jul 26, 2026
Monthly visitors increased 168% MoM.
AusperBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AusperBio's valuation, stock price, and market status.